The 2021 Medtech Contract Manufacturing Report

innovation hub

AcquiSci is Profiled in this Database

Updated At 28 Jun, 2012

Start Free 7 Day Trial Now
Partial description of this company
The d-OSAB platform technology, used to treat ischemic stroke by delivering a precise, measured dose of oxidative stressor and comprising a monitoring system that determines the amount of stressor absorbed as well as a disposable device that maximizes contact with the fluid or blood

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of AcquiSci plus 4842 other startups.

Start Free 7 Day Trial Now

Learn More About AcquiSci

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation


Our Clients